Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Gruvaktiebolaget Viscaria | VISC | 3. jan 2025 | 20.60 | -2.14 |
Gränges | GRNG | 3. jan 2025 | 132.60 | -1.63 |
Grängesberg Exploration Holding | GRANGX | 3. jan 2025 | 10.60 | -0.75 |
Guard Therapeutics International | GUARD | 3. jan 2025 | 19.90 | -1.49 |
Guideline Geo | GGEO | 3. jan 2025 | 8.66 | +3.59 |
Gullberg & Jansson | GJAB | 3. jan 2025 | 13.90 | -2.46 |
H&D Wireless Sweden Holding B | HDWB | 3. jan 2025 | 0.00 | +5.88 |
H&M B | HMB | 3. jan 2025 | 146.75 | -1.34 |
HAKI Safety A | HAKIA | 3. jan 2025 | 29.40 | +8.89 |
HAKI Safety B | HAKIB | 3. jan 2025 | 24.70 | +0.82 |
Hamlet BioPharma AB (publ) | HAMLETB | 3. jan 2025 | 3.68 | +2.22 |
Hansa Biopharma | HNSA | 3. jan 2025 | 39.80 | -0.50 |
Hanza AB | HANZA | 3. jan 2025 | 78.50 | -0.63 |
Harm Reduction Group | NOHARM | 3. jan 2025 | 0.04 | +61.87 |
Havsfrun Investment | HAVS | 3. jan 2025 | 12.60 | -0.40 |
Havsfrun Investment B | HAVB | 3. jan 2025 | 12.60 | -0.40 |
Haypp Group | HAYPP | 3. jan 2025 | 59.80 | -1.32 |
Headsent | VIMAB | 3. jan 2025 | 11.90 | +7.21 |
Heba B | HEBAB | 3. jan 2025 | 32.20 | -2.28 |
Hedera Group | HEGR | 3. jan 2025 | 3.70 | 0.00 |
Heimstaden Pref | HEIMPREF | 3. jan 2025 | 15.60 | -2.13 |
Heliospectra | HELIO | 3. jan 2025 | 0.35 | 0.00 |
Hemnet Group | HEM | 3. jan 2025 | 362.60 | +2.26 |
Hemply Balance | HMPLY | 3. jan 2025 | 0.03 | -8.82 |
Hernö Gin B | HERNOB | 3. jan 2025 | 3.94 | +0.77 |
Hexagon B | HEXAB | 3. jan 2025 | 105.40 | -0.71 |
Hexagon Purus | HPURO | 3. jan 2025 | 5.53 | +2.60 |
Hexatronic Group | HTRO | 3. jan 2025 | 37.90 | 0.00 |
Hexicon | HEXI | 3. jan 2025 | 0.19 | +12.04 |
Hexpol B | HPOLB | 3. jan 2025 | 101.70 | -1.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.